High-Dose Deferoxamine in Intracerebral Hemorrhage

NCT01662895 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

42

Enrollment

OTHER

Sponsor class

Stopped By DSMB on October 18, 2013 due to increased incidence of ARDS. See modified protocol \[NCT02175225

Conditions

Intracerebral Hemorrhage

Interventions

DRUG: Deferoxamine
DRUG: Normal saline

Sponsor

Beth Israel Deaconess Medical Center

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]